(Total Views: 279)
Posted On: 03/17/2022 1:45:50 PM
Post# of 122

$FBIO News Article - Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Rosacea https://marketwirenews.com/news-releases/jour...31763.html


My Twitter: WhyteStocks